Association between immune dysfunction and COVID-19 breakthrough infection after SARS-CoV-2 vaccination in the US

J Sun, Q Zheng, V Madhira, AL Olex… - JAMA internal …, 2022 - jamanetwork.com
Importance Persons with immune dysfunction have a higher risk for severe COVID-19
outcomes. However, these patients were largely excluded from SARS-CoV-2 vaccine …

Analysis of postvaccination breakthrough COVID-19 infections among adults with HIV in the United States

SB Coburn, E Humes, R Lang, C Stewart… - JAMA network …, 2022 - jamanetwork.com
Importance Recommendations for additional doses of COVID-19 vaccines for people with
HIV (PWH) are restricted to those with advanced disease or unsuppressed HIV viral load …

Breakthrough COVID-19 infections in the US: implications for prolonging the pandemic

DJ Alcendor, P Matthews-Juarez, D Smoot… - Vaccines, 2022 - mdpi.com
The incidence of COVID-19 breakthrough infections—an infection that occurs after you have
been vaccinated—has increased in frequency since the Delta and now Omicron variants of …

Factors associated with severe COVID-19 among vaccinated adults treated in US Veterans Affairs hospitals

AD Vo, J La, JTY Wu, JM Strymish, M Ronan… - JAMA network …, 2022 - jamanetwork.com
Importance With a large proportion of the US adult population vaccinated against SARS-
CoV-2, it is important to identify who remains at risk of severe infection despite vaccination …

[HTML][HTML] Effectiveness of first, second, and third COVID-19 vaccine doses in solid organ transplant recipients: a population-based cohort study from Canada

KL Naylor, SJ Kim, G Smith, E McArthur… - American Journal of …, 2022 - Elsevier
Limited data exists on the effectiveness of a third COVID-19 vaccine dose in solid organ
transplant recipients. We conducted a population-based cohort study using linked …

Sotrovimab therapy in solid organ transplant recipients with mild to moderate COVID-19: a systematic review and meta-analysis

N Farhadian, M Farhadian, MH Zamanian… - …, 2023 - Taylor & Francis
Purpose: Solid organ transplant recipients (SOTR) have a high risk for severe COVID-19
infection; hence it is necessary to find alternative treatment strategies to protect these …

[HTML][HTML] Augmented humoral and cellular immunity against severe acute respiratory syndrome coronavirus 2 after breakthrough infection in kidney transplant …

J Yang, KW Lee, JY Baek, S Bae, YH Lee, H Kim… - American Journal of …, 2023 - Elsevier
Diminished immune response to coronavirus disease 2019 (COVID-19) vaccines and
breakthrough infection (BI) is a major concern for solid organ transplant recipients. Humoral …

[HTML][HTML] Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients

D Kemlin, N Gemander, S Depickère… - American Journal of …, 2023 - Elsevier
As solid organ transplant recipients are at high risk of severe COVID-19 and respond poorly
to primary SARS-CoV-2 mRNA vaccination, they have been prioritized for booster …

[HTML][HTML] SARS-CoV-2 Reinfection Risk in Persons with HIV, Chicago, Illinois, USA, 2020–2022

RA Teran, A Gagner, S Gretsch… - Emerging Infectious …, 2023 - ncbi.nlm.nih.gov
Understanding if persons with HIV (PWH) have a higher risk for SARS-CoV-2 reinfection
may help tailor future COVID-19 public health guidance. To determine whether HIV infection …

Clinical effectiveness of SARS-CoV-2 vaccination in renal transplant recipients. Antibody levels impact in pneumonia and death

B Rodríguez-Cubillo, MAM de la Higuera… - …, 2022 - journals.lww.com
Background. Few studies have described the clinical impact of anti–severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) vaccines in renal transplant recipients (RTRs) in the …